Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DLO NYSE:HIMS NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDLODLocal$12.06-1.5%$12.79$9.75▼$16.78$3.56B1.042.72 million shs2.80 million shsHIMSHims & Hers Health$23.71-1.2%$24.04$13.74▼$70.43$5.41B2.4325.09 million shs14.75 million shsTEMTempus AI$46.18-0.7%$48.89$41.73▼$104.32$8.29B3.996.01 million shs4.28 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDLODLocal0.00%+9.54%-9.39%-9.93%+5.24%HIMSHims & Hers Health0.00%-5.40%-15.80%+51.76%-59.05%TEMTempus AI0.00%+5.12%-10.23%-20.88%-20.57%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDLODLocal$12.06-1.5%$12.79$9.75▼$16.78$3.56B1.042.72 million shs2.80 million shsHIMSHims & Hers Health$23.71-1.2%$24.04$13.74▼$70.43$5.41B2.4325.09 million shs14.75 million shsTEMTempus AI$46.18-0.7%$48.89$41.73▼$104.32$8.29B3.996.01 million shs4.28 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDLODLocal0.00%+9.54%-9.39%-9.93%+5.24%HIMSHims & Hers Health0.00%-5.40%-15.80%+51.76%-59.05%TEMTempus AI0.00%+5.12%-10.23%-20.88%-20.57%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDLODLocal 2.88Moderate Buy$16.6337.85% UpsideHIMSHims & Hers Health 2.12Hold$28.9021.88% UpsideTEMTempus AI 2.50Moderate Buy$68.6448.64% UpsideCurrent Analyst Ratings BreakdownLatest HIMS, DLO, and TEM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2026HIMSHims & Hers Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$23.005/22/2026HIMSHims & Hers Health Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$18.00 ➝ $23.005/19/2026HIMSHims & Hers Health Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$30.00 ➝ $28.005/13/2026HIMSHims & Hers Health Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$32.00 ➝ $30.005/12/2026HIMSHims & Hers Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Sell (D)5/12/2026HIMSHims & Hers Health Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$24.505/12/2026HIMSHims & Hers Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$35.005/12/2026HIMSHims & Hers Health Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$32.005/12/2026HIMSHims & Hers Health CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$24.00 ➝ $28.005/12/2026HIMSHims & Hers Health JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$35.00 ➝ $33.005/11/2026TEMTempus AI HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$95.00 ➝ $64.00(Data available from 5/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDLODLocal$1.09B3.25$0.91 per share13.20$1.88 per share6.41HIMSHims & Hers Health$2.37B2.28$0.84 per share28.38$1.96 per share12.10TEMTempus AI$1.27B6.52N/AN/A$2.32 per share19.91Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDLODLocal$196.80M$0.6319.1411.17N/A15.85%41.22%14.27%8/12/2026 (Estimated)HIMSHims & Hers Health$128.37M-$0.09N/A48.3946.09-0.56%6.10%1.52%8/10/2026 (Estimated)TEMTempus AI-$245.03M-$1.72N/AN/AN/A-22.20%-53.83%-11.17%N/ALatest HIMS, DLO, and TEM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026DLODLocal$0.16$0.17+$0.01$0.14$331.20 million$335.86 million5/11/2026Q1 2026HIMSHims & Hers Health$0.04-$0.40-$0.44-$0.40$616.84 million$608.10 million5/5/2026Q1 2026TEMTempus AI-$0.21-$0.13+$0.08-$0.71$345.44 million$348.12 million3/19/2026Q4 2025DLODLocal$0.18$0.18N/A$0.18$294.29 million$337.89 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDLODLocalN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/ATEMTempus AIN/AN/AN/AN/AN/ALatest HIMS, DLO, and TEM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/16/2026DLODLocalquarterly$0.19396.77%5/27/20265/27/20266/10/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDLODLocalN/A1.331.33HIMSHims & Hers Health2.181.691.56TEMTempus AI2.963.313.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDLODLocal90.13%HIMSHims & Hers Health63.52%TEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipDLODLocal45.44%HIMSHims & Hers Health11.76%TEMTempus AI24.26%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDLODLocal1,274294.93 million160.92 millionOptionableHIMSHims & Hers Health2,442227.94 million201.13 millionOptionableTEMTempus AI3,800179.57 million136.00 millionN/AHIMS, DLO, and TEM HeadlinesRecent News About These CompaniesTempus AI (TEM) Launches ArteraAI Prostate Test, The First Externally Developed Digital Pathology AlgorithmMay 24 at 10:10 AM | insidermonkey.comInsider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $597,148.50 in StockMay 24 at 6:30 AM | americanbankingnews.comInsider Selling: Tempus AI (NASDAQ:TEM) EVP Sells $383,541.21 in StockMay 24 at 4:57 AM | americanbankingnews.comTempus AI (NASDAQ:TEM) CFO Sells $478,291.71 in StockMay 24 at 4:57 AM | americanbankingnews.comEric Lefkofsky Sells 22,335 Shares of Tempus AI (NASDAQ:TEM) StockMay 23 at 4:43 AM | americanbankingnews.comTempus AI, Inc. (TEM) and Bristol Myers Announce a Strategic PartnershipMay 23 at 2:31 AM | insidermonkey.comTempus AI Stockholders Confirm Board, Auditor and Say-on-PayMay 22 at 5:31 PM | tipranks.comTempus AI: Taking Advantage Of Investor MyopiaMay 22 at 10:01 AM | seekingalpha.comTempus AI (NASDAQ:TEM) CAO Sells $181,392.12 in StockMay 22 at 8:02 AM | insidertrades.com5 Best ARK Stocks to Buy Right NowMay 21 at 7:50 PM | insidermonkey.comTempus AI Expands Cancer Platform With Launch of ArteraAI Prostate Test For Metastatic PatientsMay 21 at 5:56 PM | finance.yahoo.comTempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical UseMay 21 at 8:30 AM | businesswire.com4 Heavily Shorted AI Stocks to Watch Right NowMay 20, 2026 | schaeffersresearch.comAssessing Tempus AI (TEM) Valuation After Recent Share Price WeaknessMay 19, 2026 | finance.yahoo.comHow beaten-down Tempus AI stock offers a lottery ticket for traders hereMay 18, 2026 | msn.comTempus AI And BMS Deepen AI Drug Development Ties As Losses PersistMay 18, 2026 | finance.yahoo.com7 Healthcare AI Stocks Under $50 With Huge Upside PotentialMay 18, 2026 | 247wallst.comTempus AI, Inc. (NASDAQ:TEM) Receives Consensus Rating of "Moderate Buy" from BrokeragesMay 15, 2026 | americanbankingnews.comTempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMay 15, 2026 | marketbeat.comHere’s Why Aristotle Core Equity Fund Bets on Tempus AI (TEM), a Healthcare Technology CompanyMay 14, 2026 | insidermonkey.comTempus AI Completes Convertible Notes Offering, Retires Secured DebtMay 13, 2026 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWhat the FDA's Latest Proposal Means for Lilly, Novo, and HimsBy Leo Miller | May 7, 2026Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusBy Jessica Mitacek | May 8, 2026Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?By Jessica Mitacek | May 12, 2026Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance MeansBy Leo Miller | April 28, 2026The Silver Lining of Last Week's Hims & Hers Earnings MissBy Jessica Mitacek | May 21, 2026HIMS, DLO, and TEM Company DescriptionsDLocal NASDAQ:DLO$12.06 -0.18 (-1.47%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$11.96 -0.10 (-0.84%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DLocal Limited operates a payment processing platform worldwide. The company offers pay-in solution which the business and get paid for their products and services through various payment methods, including international and local cards, online bank transfers and direct debit, cash, and alternative payment methods. It also provides pay-out solution used for merchants to scale pay-out operations. In addition, the company offers dLocal for Platforms, an end-to-end payment solution that offers a range of services to help platforms manage payments. It serves its products to commerce, streaming, ride-hailing, financial services, advertising, SaaS, travel, e-learning, on-demand delivery, and gaming and crypto industries. DLocal Limited was founded in 2016 and is headquartered in Montevideo, Uruguay.Hims & Hers Health NYSE:HIMS$23.71 -0.30 (-1.25%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$23.67 -0.04 (-0.19%) As of 05/22/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Tempus AI NASDAQ:TEM$46.18 -0.31 (-0.67%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$46.00 -0.17 (-0.38%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Palantir and Dell Build an AI OS for the Paranoid Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
